While it cannot be excluded that MYC overexpression reshapes evolution of BRCA1-deficient TNBCs via negative selection of tumor cell clones with high levels of CNAs, amplifications of MCL1 might be particularly selected for as they may counteract the pro-apoptotic effects of MYC overexpression. Here, MCL1 is linked to neoplasm.